Have questions about the economic measures put in place to support businesses affected by the coronavirus (COVID-19)? Visit the Québec.ca.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. website.

Ouvrir ou fermer le menu de navigation

La page est en cours de chargement...  

Bannière Excellence Québec

Québec is excellence

World-class researchers and research facilities

Strenghts

Québec’s many strengths allow it to stand out on the international stage in a number of fields, such as:

  • Cardiology
  • Genomics
  • Infectious diseases
  • Imaging
  • Sports medicine
  • Neuroscience
  • Oncology
  • Digital health
  • Rehabilitation

It also excels in two cross-cutting niches:

  • Precision medicine
    Québec has made a number of big discoveries in precision medicine that have or will lead to the development of new treatments or will facilitate decision-making in disease management.
  • Big data use in health sector
    This new social and economic development sector includes many specialties, including data science, deep learning, artificial intelligence, operational research and optimization. Its aim is to create technologies facilitating and improving the detection and diagnosis of diseases like cancer, optimizing health network resource use and accelerating the discovery of new treatments.

Discoveries

Here are examples of recent discoveries made in Québec that will revolutionize the medicine of tomorrow in many areas:

Cardiology and gastroenterology

Discovery of a new heart and bowel disease

Pediatric cardiologists and researchers at CHU de Québec.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité.* and CHU Sainte-Justine.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. have discovered a new disease.

Known as chronic atrial and intestinal dysrhythmia (CAID), this rare disease disrupts the electrical system of muscle cells regulating heart and bowel functions.

*In French only.

Infectious diseases

Tracking HIV to eradicate it.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité.*

Doctor Daniel Kaufmann and his team, affiliated with Centre de recherche du Centre hospitalier de l’Université de Montréal, have developed a technique to accurately target HIV reservoirs, including CD4 lymphocytes harbouring dormant HIV. With this breakthrough, we may be able to develop drugs to treat infected cells.

*In French only.

Medical imaging

Major clinical breakthrough

Researchers at Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS) unveiled the results of a clinical study demonstrating equivalency between cyclotron-produced technetium (Tc-99m) and that produced in a nuclear reactor.

Neurology

Discovery of a small molecule could improve treatment response in depressed patients.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité.

Researchers at the Douglas Mental Health University Institute have found that levels of a tiny molecule, miR-1202, are lower in the brains of depressed individuals.

This discovery may hold a key to improving treatment options for those who suffer from depression and help detect individuals who are likely to respond to antidepressant treatment.

Oncology

World breakthrough: a new molecule allows for an increase in stem cell transplants

Researchers at Université de Montréal’s Institute for Research in Immunology and Cancer have discovered a new molecule, UM171, that could multiply by more than 10 the number of cord blood units available for human stem cell transplants.

Sports medicine

A new cognitive training system.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité.

The NeuroTracker is a cognitive training system developed at Dr. Jocelyn Faubert’s optometry and psychophysics laboratory at Université de Montréal. Commercialized since 2009, the system recreates game environments to help athletes better divide their attention and improve their vision.

Precision medicine

Characterization of the impact of gene mutations BRCA1 and BRCA2.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité.

Dr. Jacques Simard was involved in characterizing the impact of mutations BRCA1 and BRCA2 in breast and ovarian cancer susceptibility genes. Identifying these gene mutations allows women who are carriers to make important health-related decisions that can lead to more active preventive measures (e.g., screening, preventive surgery/chemotherapy).

Big data use in healthcare

Biplanar X-ray technology.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité.

Jacques de Guise and his team, in collaboration with EOS Imaging and Arts et Métiers ParisTech, have developed biplanar (front and side) X-ray technology for creating 3D bone and skeleton models.

Promising projects

A pool of promising projects to discover

The Government of Québec supports many organizations in order to promote innovative and promising university research projects.

Commercialization companies

The purpose of Québec’s three commercialization companies is to bring to market technologies based on conclusive research conducted at universities, affiliated research centres and university hospitals.

Here are Québec’s three commercialization companies:

  • Aligo Innovation .  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité.  (Université du Québec, Concordia University, McGill University, Bishop’s University and Université de Sherbrooke)
  • Sovar.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. (Université Laval)
  • Univalor.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. (Université de Montréal)

Facilities

Québec is currently investing over $25 billion to modernize its research and healthcare facilities. Four new hospitals will be built with these funds:

  • New hospital complex at Centre hospitalier universitaire de Québec – Université Laval
  • CHU Sainte-Justine
  • Research Institute of the McGill University Health Centre
  • Centre hospitalier de l’Université de Montréal

Three world-class research centres were also built with $905 million in funding:

  • Université de Montréal Hospital Research Centre
  • Research Institute of the McGill University Health Centre
  • Sainte-Justine University Hospital Research Centre

Over 125,000 m2 will be dedicated to research.

For a full list of public research facilities: Public research facilities directory

Biobanks of interest to research

*In French only.

Last update: April 30 2020

Ministère de l'Économie et de l'Innovation

© Gouvernement du Québec, 2020

Suivez-nous

  • LinkedIn
  • Youtube
  • Instagram